• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HNRNPC 通过 m6A 甲基化调节 PKM 的可变剪接,上调 PKM2 表达,促进甲状腺乳头状癌的有氧糖酵解并驱动恶性进展。

HNRNPC modulates PKM alternative splicing via m6A methylation, upregulating PKM2 expression to promote aerobic glycolysis in papillary thyroid carcinoma and drive malignant progression.

机构信息

Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China.

Department of Thyroid and Hernia Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, Guangdong, China.

出版信息

J Transl Med. 2024 Oct 8;22(1):914. doi: 10.1186/s12967-024-05668-9.

DOI:10.1186/s12967-024-05668-9
PMID:39380010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11459990/
Abstract

The heterogeneous nuclear ribonucleoprotein C (HNRNPC) plays a crucial role in tumorigenesis, yet its role in papillary thyroid carcinoma (PTC) remains elusive. Herein, we elucidated the function and molecular mechanism of HNRNPC in PTC tumorigenesis and progression. Our study unveiled a significant upregulation of HNRNPC in PTC, and knockdown of HNRNPC markedly inhibited the proliferation, invasion, and metastasis of BCPAP cells. Furthermore, HNRNPC modulated PKM alternative splicing in BCPAP cells primarily through m6A modification. Additionally, by upregulating PKM2 expression, HNRNPC promoted aerobic glycolysis in BCPAP cells, thereby facilitating malignant progression in PTC. In summary, our findings demonstrate that HNRNPC regulates PKM alternative splicing through m6A methylation modification and promotes the proliferation, invasion and metastasis of PTC through glucose metabolism pathways mediated by PKM2. These discoveries provide new biomarkers for screening and diagnosing PTC patients and offer novel therapeutic targets for personalized treatment strategies.

摘要

异质核核糖核蛋白 C(HNRNPC)在肿瘤发生中起着至关重要的作用,但它在甲状腺乳头状癌(PTC)中的作用仍不清楚。在此,我们阐明了 HNRNPC 在 PTC 发生和进展中的功能和分子机制。我们的研究揭示了 HNRNPC 在 PTC 中的显著上调,敲低 HNRNPC 可显著抑制 BCPAP 细胞的增殖、侵袭和转移。此外,HNRNPC 通过 m6A 修饰主要调节 BCPAP 细胞中的 PKM 可变剪接。此外,通过上调 PKM2 的表达,HNRNPC 促进了 BCPAP 细胞的有氧糖酵解,从而促进了 PTC 的恶性进展。综上所述,我们的研究结果表明,HNRNPC 通过 m6A 甲基化修饰调节 PKM 可变剪接,并通过 PKM2 介导的葡萄糖代谢途径促进 PTC 的增殖、侵袭和转移。这些发现为 PTC 患者的筛查和诊断提供了新的生物标志物,并为个性化治疗策略提供了新的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be84/11459990/ad961f4e3dfc/12967_2024_5668_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be84/11459990/1c8e1d1dc8c7/12967_2024_5668_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be84/11459990/54bdf551dd4e/12967_2024_5668_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be84/11459990/14b72f396c13/12967_2024_5668_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be84/11459990/977e00f2e66f/12967_2024_5668_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be84/11459990/d9e6de825f9b/12967_2024_5668_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be84/11459990/2815b3d6f176/12967_2024_5668_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be84/11459990/ad961f4e3dfc/12967_2024_5668_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be84/11459990/1c8e1d1dc8c7/12967_2024_5668_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be84/11459990/54bdf551dd4e/12967_2024_5668_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be84/11459990/14b72f396c13/12967_2024_5668_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be84/11459990/977e00f2e66f/12967_2024_5668_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be84/11459990/d9e6de825f9b/12967_2024_5668_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be84/11459990/2815b3d6f176/12967_2024_5668_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be84/11459990/ad961f4e3dfc/12967_2024_5668_Fig7_HTML.jpg

相似文献

1
HNRNPC modulates PKM alternative splicing via m6A methylation, upregulating PKM2 expression to promote aerobic glycolysis in papillary thyroid carcinoma and drive malignant progression.HNRNPC 通过 m6A 甲基化调节 PKM 的可变剪接,上调 PKM2 表达,促进甲状腺乳头状癌的有氧糖酵解并驱动恶性进展。
J Transl Med. 2024 Oct 8;22(1):914. doi: 10.1186/s12967-024-05668-9.
2
PTBP1 crotonylation promotes colorectal cancer progression through alternative splicing-mediated upregulation of the PKM2 gene.PTBP1 琥珀酰化通过选择性剪接介导的 PKM2 基因上调促进结直肠癌的进展。
J Transl Med. 2024 Nov 4;22(1):995. doi: 10.1186/s12967-024-05793-5.
3
CircPHGDH downregulation decreases papillary thyroid cancer progression through miR-122-5p/PKM2 axis.环状磷酸甘油酸脱氢酶(CircPHGDH)下调通过miR-122-5p/丙酮酸激酶M2(PKM2)轴降低甲状腺乳头状癌的进展。
BMC Cancer. 2024 Apr 23;24(1):511. doi: 10.1186/s12885-024-12199-5.
4
SAM68 promotes tumorigenesis in lung adenocarcinoma by regulating metabolic conversion via PKM alternative splicing.SAM68 通过调节 PKM 可变剪接促进肺腺癌的肿瘤发生。
Theranostics. 2021 Jan 19;11(7):3359-3375. doi: 10.7150/thno.51360. eCollection 2021.
5
FTO/IGF2BP2-mediated N6 methyladenosine modification in invasion and metastasis of thyroid carcinoma via CDH12.FTO/IGF2BP2 介导的 N6 甲基腺苷修饰通过 CDH12 促进甲状腺癌的侵袭和转移。
Cell Death Dis. 2024 Oct 8;15(10):733. doi: 10.1038/s41419-024-07097-4.
6
Dietary-phytochemical mediated reversion of cancer-specific splicing inhibits Warburg effect in head and neck cancer.膳食植物化学物质介导的癌症特异性剪接逆转抑制头颈部癌症的瓦博格效应。
BMC Cancer. 2019 Nov 1;19(1):1031. doi: 10.1186/s12885-019-6257-1.
7
ALKBH5, an m6A demethylase, attenuates tumor growth and inhibits metastasis in papillary thyroid carcinoma.ALKBH5是一种m6A去甲基化酶,可减弱甲状腺乳头状癌的肿瘤生长并抑制转移。
Sci Rep. 2025 Jan 9;15(1):1514. doi: 10.1038/s41598-024-84352-w.
8
Correction to: HNRNPC modulates PKM alternative splicing via m6A methylation, upregulating PKM2 expression to promote aerobic glycolysis in papillary thyroid carcinoma and drive malignant progression.对以下内容的修正:HNRNPC通过m6A甲基化调节PKM可变剪接,上调PKM2表达以促进甲状腺乳头状癌的有氧糖酵解并推动恶性进展。
J Transl Med. 2025 Feb 18;23(1):201. doi: 10.1186/s12967-025-06130-0.
9
HNRNPC mediates lymphatic metastasis of cervical cancer through m6A-dependent alternative splicing of FOXM1.HNRNPC 通过 FOXM1 的 m6A 依赖性可变剪接介导宫颈癌的淋巴转移。
Cell Death Dis. 2024 Oct 7;15(10):732. doi: 10.1038/s41419-024-07108-4.
10
METTL3-mediated m6A Modification of hsa_circ_0131922 Attenuates the Progression of Papillary Thyroid Cancer by Regulating the p53 Pathway.METTL3介导的hsa_circ_0131922的m6A修饰通过调控p53通路减弱甲状腺乳头状癌的进展。
Endocr Metab Immune Disord Drug Targets. 2025;25(6):492-502. doi: 10.2174/0118715303290063240530053252.

引用本文的文献

1
Crosstalk between lactylation and RNA modifications in tumorigenesis: mechanisms and therapeutic implications.肿瘤发生过程中乳酸化与RNA修饰之间的相互作用:机制及治疗意义
Biomark Res. 2025 Aug 26;13(1):110. doi: 10.1186/s40364-025-00824-9.
2
M6A RNA modification: focusing on non-small cell lung cancer progression, therapeutic strategies and challenges.m6A RNA修饰:聚焦于非小细胞肺癌的进展、治疗策略及挑战
Front Oncol. 2025 Jul 16;15:1622359. doi: 10.3389/fonc.2025.1622359. eCollection 2025.
3
Epitranscriptomics Regulation of CD70, CD80, and TIGIT in Cancer Immunity.

本文引用的文献

1
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
2
USP39 promotes hepatocellular carcinogenesis through regulating alternative splicing in cooperation with SRSF6/HNRNPC.USP39 通过与 SRSF6/HNRNPC 合作调节选择性剪接促进肝细胞癌发生。
Cell Death Dis. 2023 Oct 11;14(10):670. doi: 10.1038/s41419-023-06210-3.
3
Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics.
癌症免疫中CD70、CD80和TIGIT的表观转录组学调控
Int J Mol Sci. 2025 Jun 16;26(12):5772. doi: 10.3390/ijms26125772.
4
RBM15-mediated metabolic reprogramming boosts immune response in colorectal cancer.RBM15介导的代谢重编程增强结直肠癌中的免疫反应。
Front Immunol. 2025 Apr 30;16:1515568. doi: 10.3389/fimmu.2025.1515568. eCollection 2025.
5
Correction to: HNRNPC modulates PKM alternative splicing via m6A methylation, upregulating PKM2 expression to promote aerobic glycolysis in papillary thyroid carcinoma and drive malignant progression.对以下内容的修正:HNRNPC通过m6A甲基化调节PKM可变剪接,上调PKM2表达以促进甲状腺乳头状癌的有氧糖酵解并推动恶性进展。
J Transl Med. 2025 Feb 18;23(1):201. doi: 10.1186/s12967-025-06130-0.
肿瘤微环境中的脂质代谢重编程:从机制到治疗。
J Hematol Oncol. 2023 Sep 12;16(1):103. doi: 10.1186/s13045-023-01498-2.
4
RBX1 regulates PKM alternative splicing to facilitate anaplastic thyroid carcinoma metastasis and aerobic glycolysis by destroying the SMAR1/HDAC6 complex.RBX1通过破坏SMAR1/HDAC6复合物来调节PKM可变剪接,以促进间变性甲状腺癌转移及有氧糖酵解。
Cell Biosci. 2023 Feb 21;13(1):36. doi: 10.1186/s13578-023-00987-8.
5
LINC00924-induced fatty acid metabolic reprogramming facilitates gastric cancer peritoneal metastasis via hnRNPC-regulated alternative splicing of Mnk2.LINC00924 诱导的脂肪酸代谢重编程通过 hnRNPC 调控的 Mnk2 可变剪接促进胃癌腹膜转移。
Cell Death Dis. 2022 Nov 23;13(11):987. doi: 10.1038/s41419-022-05436-x.
6
Tumor glycolysis, an essential sweet tooth of tumor cells.肿瘤糖酵解,肿瘤细胞的一种基本嗜糖特性。
Semin Cancer Biol. 2022 Nov;86(Pt 3):1216-1230. doi: 10.1016/j.semcancer.2022.09.007. Epub 2022 Oct 28.
7
Long non-coding RNA VAL facilitates PKM2 enzymatic activity to promote glycolysis and malignancy of gastric cancer.长链非编码 RNA VAL 促进 PKM2 的酶活性,从而促进胃癌的糖酵解和恶性进展。
Clin Transl Med. 2022 Oct;12(10):e1088. doi: 10.1002/ctm2.1088.
8
Warburg-like metabolic transformation underlies neuronal degeneration in sporadic Alzheimer's disease.散发性阿尔茨海默病中的神经元退行性变与沃伯格样代谢转化有关。
Cell Metab. 2022 Sep 6;34(9):1248-1263.e6. doi: 10.1016/j.cmet.2022.07.014. Epub 2022 Aug 19.
9
lncRNA CYTOR promotes aberrant glycolysis and mitochondrial respiration via HNRNPC-mediated ZEB1 stabilization in oral squamous cell carcinoma.长链非编码 RNA CYTOR 通过 HNRNPC 介导的 ZEB1 稳定促进口腔鳞状细胞癌中的异常糖酵解和线粒体呼吸。
Cell Death Dis. 2022 Aug 13;13(8):703. doi: 10.1038/s41419-022-05157-1.
10
Role of m6A writers, erasers and readers in cancer.m6A甲基化修饰的写入器、擦除器和读取器在癌症中的作用。
Exp Hematol Oncol. 2022 Aug 9;11(1):45. doi: 10.1186/s40164-022-00298-7.